A new study conducted by the University of Southern California supports short-term fasting could assist chemotherapy cancer treatments.
The study was recently published in the Science Translation Medicine Journal and research shows that when cancer patients abstain from food for a short time while undergoing chemotherapy treatment, some cancers were cured. Cancers included breast, melanoma and giloma cells.
The results were true for the lab mice and the next step is more detailed research.
“A way to beat cancer cells may not be to try to find drugs that kill them specifically but to confuse them by generating extreme environments, such as fasting those only normal cells can quickly respond to,” said Professor Valter Longo, the study’s lead researcher to Healthcare Global.
Scientists warn for patients not to read this information and begin fasting, more research needs to be complete to see if the results would be similar for humans.
To read more about fasting boosting chemotherapy treatments, please see healthcareglobal.com.
A Selenia Deimensions breast tomosythesis machine.
This February, the University of Kentucky Markey Cancer Center will begin offering state-of-the-art digital tomosynthesis for breast cancer screenings. UK will become the first and only medical center in Kentucky to use this new 3-D technology, the Lexington hospital announced in a release.
Tomosythesis will be used by radiologist to see patient’s breast structure, eliminating confusion of overlapping tissues. During a mammogram, tomosythesis technology will take multiple X-ray photos of the breast and from many angles. A computer will process the photos and create a 3-D image for radiologists. The new technology is believed to find much smaller and earlier stages of cancers that can be missed in a traditional mammogram.
“Tomosynthesis produces images in tiny slices that can be reconstructed into a 3-D image of the tissue, similar to way a CT scanner works,” Dr. Margaret Szabunio, associate medical director at UK’s Comprehensive Breast Cancer Center, said in a statement. “It allows us to look at breast tissue in a way we’ve never been able to before.”
UK plans to begin using tomosynthesis on patients this month. Patients who had an abnormality on a regular mammogram will come in for a tomosynthesis as their follow-up, according to the release.
Tomosynthesis will be used as a regular screening tool for women who are at a high risk of breast cancer or who have dense breast tissue.
“Tomosynthesis digital breast imaging will be of great benefit to our patients when it comes to detecting breast cancer in its early stages,” Dr. Mark Evers, director of the UK Markey Cancer Center, said in a statement. “The earlier a cancer is detected, the higher a patient’s chances are for a full recovery. This technology has the potential to save many, many lives.”